Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model

Various combination treatments have been considered to attain the effective therapy threshold by combining independent antitumor mechanisms against the heterogeneous characteristics of tumor cells in malignant brain tumors. In this study, the natural killer (NK) cells associated with bevacizumab (Be...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Thi-Anh-Thuy, Kim, Young-Hee, Duong, Thi-Hoang-Oanh, Thangaraj, JayaLakshmi, Chu, Tan-Huy, Jung, Shin, Kim, In-Young, Moon, Kyung-Sub, Kim, Young-Jin, Lee, Tae-Kyu, Lee, Chul Won, Yun, Hyosuk, Lee, Je-Jung, Lee, Hyun-Ju, Lee, Kyung-Hwa, Jung, Tae-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871756/
https://www.ncbi.nlm.nih.gov/pubmed/36703992
http://dx.doi.org/10.3389/fimmu.2022.1009484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871756/
https://www.ncbi.nlm.nih.gov/pubmed/36703992
http://dx.doi.org/10.3389/fimmu.2022.1009484

Ejemplares similares